Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. develops, commercializes, sells and distributes branded e-cigarettes and cannabis vaping products. Its e-cigarette products are marketed under the Aspire name through a global distribution network, while cannabis vaping hardware is sold under the Ispire brand, primarily through original design manufacture relationships with other cannabis vapor companies.
Recurring ISPR news includes quarterly financial results, cash and working-capital updates, product and customer activity, manufacturing and distribution developments, and regulatory technology initiatives for electronic nicotine delivery systems. Coverage also includes IKE Tech, a joint venture involving Ispire, and its age-gating, authentication and point-of-use compliance technology tied to FDA discussions, PMTA submissions and flavored ENDS regulation.
WM Technology (Nasdaq: MAPS) appointed Harry DeMott and Brent Cox to its Board of Directors effective February 1, 2026, and confirmed Susan Echard will transition from a contracted CFO role to full employment effective January 30, 2026. The additions emphasize cannabis industry, technology, and capital markets experience.
The company said the new directors bring board and operating experience to support Weedmaps marketplace and the firm's growth in the evolving cannabis sector.
Ispire Technology (NASDAQ: ISPR) will hold its fiscal second quarter 2026 earnings conference call at 8:00 am ET on Friday, February 6, 2026 to discuss results for the quarter ended December 31, 2025. The call is available by dial-in or live webcast.
Dial-in numbers include US 877-451-6152 and International +1 201-389-0879. The webcast link is provided for registration; attendees should access it at least fifteen minutes early. A playback replay will be available through 11:59 pm ET on February 20, 2026 with passcode 13758138.
Credit Acceptance (Nasdaq: CACC) announced an amendment extending its $100.0 million asset-backed non-recourse secured financing (Term ABS 2021-1). The financing's revolve stop date was extended from February 17, 2026 to January 18, 2028. The borrowing spread was reduced from SOFR + 220 bps to SOFR + 140 bps, with no other material term changes.
The company reiterated its business description and provided investor contact details.
Ispire Technology (NASDAQ: ISPR) will unveil a fully reengineered cannabis hardware ecosystem at MJBizCon 2025, Dec 2–5 at the Las Vegas Convention Center. The launch introduces three product families—E-Series (Essentials), S-Series (Specialized) and C-Series (Custom/ODM)—with devices designed for varied oil viscosities, activation types (draw/button/dual) and global compliance. Key models include compact draw-activated and high-viscosity units, flagship dual-activation devices, and fully custom ODM options. Senior executives, including VP of Sales John Monds, will be available for on-site meetings; scheduling via john.monds@getispire.com.
Ispire Technology (NASDAQ: ISPR) and IKE Tech responded to the U.S. Food and Drug Administration's new enforcement direction under the Nov. 17, 2025 continuing resolution that requires the FDA to allocate at least $200 million of its $712 million in user fees to ENDS enforcement and to fund a multi-agency task force with $2 million for removing illegal imports.
Both companies promoted their blockchain-enabled, FDA-submitted System-on-a-Chip and age-verification solutions as technology to enable real-time product tracing, device-level identity validation, and interoperability to curb illicit disposable vapes and protect youth in the $30 billion flavored vape market.
Ispire Technology (NASDAQ: ISPR) will host its fiscal first quarter 2026 earnings conference call at 8:00 am ET on Thursday, November 6, 2025 to discuss results for the quarter ended September 30, 2025.
Dial-in numbers: US 844-826-3033 or International +1 412-317-5185; ask for the "Ispire Technology Call." The call will be webcast live at https://viavid.webcasts.com/starthere.jsp?ei=1738889&tp_key=82f919c8ba (register 15 minutes early to install audio software).
A replay will be available through midnight ET on Thursday, November 20, 2025 via dial 844-512-2921 or +1 412-317-6671 using passcode 10203874.
Ispire Technology Inc. (NASDAQ: ISPR) reported challenging financial results for fiscal year 2025, with revenue declining to $127.5 million from $151.9 million in FY2024. The company's strategic shift from cannabis to nicotine sectors led to decreased gross profit of $22.6 million and widened net loss to $39.2 million.
Key developments include progress in PMTA activities through IKE Tech LLC joint venture, featuring blockchain-based age verification technology. The company reported $18M in backlog orders entering Q1 2026 and implemented cost-cutting measures resulting in $10.2 million in annual payroll savings. As of June 30, 2025, Ispire maintained $24.4 million in cash and cash equivalents with working capital of $0.4 million.
Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal fourth quarter and full year 2025 earnings conference call for September 16, 2025, at 8:00 AM ET.
The call will discuss financial results for the period ended June 30, 2025. Investors can access the call through North American toll-free number (877-451-6152) or International number (+1 201-389-0879). A live webcast will be available, and a replay will be accessible until September 30, 2025, using passcode 13755309.